Lunai Bioworks Inc. — Director's Dealing 2021

Dec 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Enochian Biosciences Inc (ENOB)
CIK: 0001527728
Period of Report: 2021-10-11

Reporting Person: Gronfeldt-Sorensen Henrik (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-11	Option to purchase shares of common stock	$7.13	A	10519	Acquired	2031-10-11	Common stock (10519)	Indirect

Footnotes

F1: On October 11, 2021, Mr. Gronfeldt-Sorensen was granted an option to purchase 10,519 shares of common stock of Enochian Biosciences Inc., said option to vest on October 11, 2022.